Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF
Phase 1
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: Human recombinant epidermal growth factorOther: Placebo cream
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2012-08-03
- Lead Sponsor
- Ennar Pharmaceuticals AF
- Target Recruit Count
- 24
- Registration Number
- NCT01566578
- Locations
- 🇨🇭
University Hospital Zurich, Dermatology Clinic, Zurich, Switzerland
News
No news found